Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Centre Léon Bérard · Institut Curie · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
740
total citations
- FWCI
- 37.74
- Percentile
- 100%
- References
- 36
Citations per year
Authors
16Topics & keywords
Topics
Keywords
- Capecitabine
- Lapatinib
- Medicine
- Metastatic breast cancer
- Internal medicine
- Breast cancer
- Clinical endpoint
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.